Navigation Links
CryoLife's Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World
Date:9/3/2009

ATLANTA, Sept. 3 /PRNewswire-FirstCall/ -- More than 130 cardiovascular surgeons from approximately 30 countries are scheduled to attend the second annual global Ross Summit, a two-day surgical congress focused on the highly complex Ross Procedure, which is performed on up to 1,500 individuals globally each year -- a number that is expected to increase as survival data become more widely published.

CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, will convene the summit at its corporate headquarters training facility in suburban Atlanta Sept. 25-26. The forum provides an opportunity to review and discuss current peer-reviewed data from the world's experts relating to the survival advantage of the Ross Procedure and technical nuances required to perform the operation successfully.

The Ross Procedure is a type of specialized aortic valve surgery in which the patient's diseased aortic valve is replaced with his or her own pulmonary valve. The pulmonary valve can then be replaced with a cryopreserved human pulmonary valve.

Pioneered in 1967, by Mr. Donald N. Ross, FRCS in London, U.K., the procedure is a complex surgical technique that is performed by surgeons skilled in reconstructive cardiac surgery due to the level of technical expertise required to execute the procedure.

"In children, young adults and in active older adults, the Ross Procedure offers several advantages over other traditional aortic valve replacement options," said Dr. William Northrup III, vice president of physic
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
2. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
3. avVaa World Health Care Products, Inc. Announces the completion of its first week of DRTV 120/60 second test commercials for Neuroskin(R) Psoriasis Relief
4. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
5. Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing
6. Encorium Reports Second Quarter 2009 Financial Results
7. Los Gatos Research Introduces Second Generation Liquid-Water Isotope Analyzer
8. Spherix Reports Second Quarter 2009 Earnings
9. Lotus Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
10. NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results
11. China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... -- Nektar Therapeutics (Nasdaq: NKTR ) announced ... serve on its board of directors. Winger ... 35 years of experience in corporate management, financial ... extensive industry perspective at an important time in ... and CEO of Nektar and member of the ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... HONG KONG, Feb. 18 /PRNewswire-Asia/ -- Obio ... business growth ticket to the,international pharmaceutical arena. ... backed up by strong international investors including ... Group, Tai Sang Land Properties,Limited, Yu Hwa ...
... PharmaNet Development Group, Inc. (the "Company") (Nasdaq: ... to innovative pharmaceutical, biotechnology, generic drug and medical device ... in Sao Paulo, Brazil to further enhance its Latin ... Latin America since 2002 with a network of field-based ...
... Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE ... months ended December 31, 2008. Net loss for the three ... per share, compared with a net loss of $1,049,838 or ... 31, 2007. This increase in net loss was primarily ...
Other Biology Technology:Obio Pharmaceutical Announces Product Growth Strategy 2Obio Pharmaceutical Announces Product Growth Strategy 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 2PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 3PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 4PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 7
(Date:12/11/2009)... wild apples that could be an ancestor of today,s ... Asia. A new study comparing the diversity of recently ... Armenia with previously collected varieties originating in Russia and ... collection that will make M. orientalis more ... identify and record the genetic diversity of these wild ...
(Date:12/11/2009)... stress collectively weigh and initiate different survival strategies say ... strategic decisions that affect their health, wealth and the ... this week in the early online edition of the ... , was accomplished when the scientists applied the mathematical ... of genes and proteins that colonies of bacteria rely ...
(Date:12/11/2009)... University has granted an 18-month, exclusive option to ... insulin analogs. The company must reach certain milestones ... an exclusive license on therapies designed to help ... developing treatments that it hopes will become an ... insulin market. Insulin is a therapeutic protein used ...
Breaking Biology News(10 mins):Understanding apples' ancestors 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 1Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 2Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 1Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 2Protein Branded As Culprit in Mad Cow Disease 48638 1Protein Branded As Culprit in Mad Cow Disease 48638 2
... of Medicine scientists in the Department of Physiology and Cell Biology ... chromosome that may have significant implications for male infertility and contraception. ... This important discovery has been published in Nature ... biomedical research based upon the impact factor. , ...
... levels of carbon dioxide in the atmosphere are a ... The lack of atmospheric carbon dioxide (CO 2 ) ... their aquatic relatives, microalgae. , For plants and microalgae, ... their photosynthesis process that, along with sunlight, manufactures sugars ...
... Max Perutz was a campaigner for humanitarian causes, essayist, and ... has just been released by Cold Spring Harbor Laboratory Press. ... letters in the book What a Time I am ... life through his own vivid, erudite, and humorous pen. , ...
Other Biology News:Small RNAs can play critical roles in male infertility/contraception 2ISU researcher identifies protein that concentrates carbon dioxide in algae 2Selected personal letters of Max Perutz are released in new book 2
Mouse monoclonal [TONI-1] to Angiotensin II Type 1 Receptor (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 185 SwissProtID: P30556...
1/4" to 1/8" Adapter for Reflectance Probe Holder...
... Glucagon-like peptide-1(7-36) amide (GLP-1), C-terminal reactive. ... shows <0.1% cross reactivity with the ... other related peptides such as hGLP-2, ... mammalian species. GLP-1 is identical in ...
Human/Mouse/Rat AMPK beta 1 Affinity Purified Polyclonal Ab...
Biology Products: